Numerous recalls have been issued this year due to the potential for damaged products and undeclared food allergens.

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Texas Attorney General Ken Paxton has asked a federal judge to force the makers of Tylenol to stop any advertising that the ...

The dramatic shift in oversight comes at a time when the U.S. has never been more reliant on foreign food, which accounts for ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

Germany's Merck KGgA said on Monday it has agreed to pay Swiss biotech Debiopharm up to 900 million euros ($1.08 billion) to ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

American inspections of foreign food facilities—which produce everything from crawfish to cookies for the US market—have ...